In this post, Fancy Comma, LLC’s Sheeva Azma talks about what neuroplasticity is and how it helps humans be more adaptable.
Dawn Beauchamp shares how she has been able to achieve balance amidst the chaos of parenting, work, and life during the COVID-19 pandemic.
In this post, Fancy Comma, LLC’s Sheeva Azma reflects on the state of biomedical science journalism in the COVID-19 pandemic.
In Part 1 of this two-part series, Fancy Comma, LLC’s Kelly Tabbutt discusses the simplest ways to understand numbers and graphs when interpreting statistics in the social sciences.
In this post, Nidhi Parekh of The Shared Microscope talks about Novavax, a protein subunit vaccine being developed for COVID-19.
Learn more about CoronaVac, a COVID-19 inactivated vaccine being developed by Sinovac in China, in this post by Nidhi Parekh of The Shared Microscope.
Read our quick primer on “pitching” story ideas to the media. Our post will help you write the most effective pitches to get your articles published.
Is a post-COVID-19 world possible? Will COVID-19 become endemic? Should we have done it all differently? What about a vaccine? What are the major troubles we are facing? Nidhi Parekh of The Shared Microscope examines what the experts have to say on these questions.
We speak to a participant in the Oxford/AstraZeneca vaccine trials for COVID-19 about what it’s like.
Learn everything you need to know about technical writing in this post.